Jump to Navigation

Publicaties 2010

Publicaties 2010:

  • Beckers MMJ, Ruven HJT, Haas FJLM, Doevendans PA, ten Cate H, Prins MH, Biesma DH. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism. EUR J INTERN MED 2010;21(4):289-292.  

 

  • Beckers MMJ, Ruven HJT, Seldenrijk CA, Prins MH, Biesma DH. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. THROMB RES 2010;125(4):318-321.  

 

  • Biemond BJ. Endoscopic ultrasonography and pancreatic cancer - close companions. NETH J MED 2010;68(9):341-342.     [ PubMed ]

 

  • Biemond BJ. Treatment considerations for primary myelofibrosis. NETH J MED 2010;68(1):291-292.     [ PubMed ]

 

  • Bilgin YM, van de Watering LMG, Versteegh MIM, van Oers MHJ, Brand A. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. CRIT CARE MED 2010;38(2):546-552.     [ PubMed ]

 

  • Broyl A, Hose D, Lokhorst H, de Knegt Y, Peeters J, Jauch A, Bertsch U, Buijs A, Stevens-Kroef M, Beverloo HB, Vellenga E, Zweegman S, Kersten MJ, van der Holt B, el Jarari L, Mulligan G, Goldschmidt H, van Duin M, Sonneveld P. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. BLOOD 2010;116(14):2543-2553.     [ PubMed ]

 

  • Cherpanath TGV, Nieuwdorp M, Hazenberg MD, van Eeden S, van der Sluijs AF. Large nocturnal eyes causing gastrointestinal bleeding in asymptomatic multiple myeloma. CMV enterocolitis. NETH J MED 2010;68(10):324-327.     [ PubMed ]

 

  • Chomienne C, Guenova M, Hagenbeek A, Lacombe C, McCann S, Foa R. 15th Congress of European Hematology Association. EXPERT REV HEMATOL 2010;3(5):541-542.     [ PubMed ]

 

  • Clare S, Mank A, Stone R, Davies M, Potting C, Apperley JF. Management of related donor care: a European survey. BONE MARROW TRANSPL 2010;45(1):97-101.     [ PubMed ]

 

  • Coiffier B, Losic N, Rønn BB, Lepretre S, Pedersen LM, Gadeberg O, Frederiksen H, van Oers MHJ, Wooldridge J, Kloczko J, Holowiecki J, Hellmann A, Walewski J, Robak T, Petersen J. Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study. BRIT J HAEMATOL 2010;150(1):58-71.     [ PubMed ]

 

  • Deenik W, Janssen JJWM, van der Holt B, Verhoef GEG, Smit WM, Kersten MJ, Daenen SMGJ, Verdouck LF, Ferrant A, Schattenberg AVMB, Sonneveld P, Kooy MVM, Wittebol S, Willemze R, Wijermans PW, Beverloo HB, Lowenberg B, Valk PJM, Ossenkoppele GJ, Cornelissen JJ. Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia. HAEMATOL-HEMATOL J 2010;95(6):914-921.  

 

  • Hodiamont CJ, Huisman C, Spanjaard L, van Ketel RJ. Kytococcus schroeteri Pneumonia in Two Patients with a Hematological Malignancy. INFECTION 2010;38(2):138-140.     [ PubMed ]

 

  • Huijgens PC, Zweegman S, Hagenbeek A. Hemato-oncologie  (hfdstk 9).  In: Stehouwer CDA, Koopmans RP, Meer J van der, editors. Interne geneeskunde; 14e druk. Houten: Bohn Stafleu van Loghum; 2010. p. 283-310.

 

  • Kaandorp SP, Lauw MN, van der Schoot CE, Goddijn M, van der Veen F, Koene HR, Biemond BJ, Middeldorp S. Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage. J THROMB HAEMOST 2010;8(12):2837-2839.     [ PubMed ]

 

  • Kamphuis MM, Paridaans N, Porcelijn L, de Haas M, van der Schoot CE, Brand A, Bonsel GJ, Oepkes D. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG-INT J OBSTET GY 2010;117(11):1335-1343.     [ PubMed ]

 

  • Kater AP, Tonino SH. Standards for the Treatment of Relapsed Chronic Lymphocytic Leukemia: A Case-Based Study. CLIN LYMPHOMA MYELOM 2010;10(Suppl. 1):S34-S41.  

 

  • Khajouei R, Peek N, Wierenga PC , Kersten MJ , Jaspers MWM. Effect of predefined order sets and usability problems on efficiency of computerized medication ordering. INT J MED INFORM 2010;79(10):690-698.     [ PubMed ]

 

  • Kneppers E, Lokhorst HM, Eeltink CM, Huls G, Kersten MJ, Koedam J, Minnema MC, van Oers MHJ, Raymakers RAP, Schaafsma MR, Vellenga E, Wijermans PW, Wittebol S, Sonneveld P, Zweegman S. Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program. CLIN LYMPHOMA MYELOM 2010;10(2):138-143.     [ PubMed ]

 

  • Koelewijn JM, de Haas M, Vrijkotte TGM, van der Schoot CE, Bonsel GJ. Risk Factors for RhD Immunisation Despite Antenatal and Postnatal Anti-D Prophylaxis COMMENT. OBSTET GYNECOL SURV 2010;65(1):4-5.

 

  • Koetsier M, Nur E, Chunmao H, Lutgers HL, Links TP, Smit AJ, Rakhorst G, Graaff R. Skin color independent assessment of aging using skin autofluorescence. OPT EXPRESS 2010;18(14):14416-14429.  

 

  • Landburg PP, Teerlink T, Biemond BJ, Brandjes DPM, Muskiet FAJ, Duits AJ, Schnog JB. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. BLOOD CELL MOL DIS 2010;44(4):229-232.  

 

  • Lokhorst HM, van der Holt B, Zweegman S, Vellenga E, Croockewit S, van Oers MH, von dem Borne P, Wijermans P, Schaafsma R, de Weerdt O, Wittebol S, Delforge M, Berenschot H, Bos GM, Jie KSG, Sinnige H, van Marwijk-Kooy M, Joosten P, Minnema MC, van Ammerlaan R, Sonneveld P. A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma. BLOOD 2010;115(6):1113-1120.     [ PubMed ]

 

  • Lokhorst HM, von dem Borne PA, Kersten MJ. HOVON 108: T-cel-gedepleteerde niet-myeloablatieve allogene stamceltransplantatie gevolgd door vroege consolidatie met lenalidomide of lenalidomide gecombineerd met bortezomib en aanvullend donorlymfocyteninfusie voor patiënten met een eerste recidief of progressie na eerstelijnsbehandeling. NED TIJDSCHR HEMATOL 2010;7(8):332-338.  

 

  • Lugtenburg P, Hagenbeek A. Treatment of early favorable Hodgkin lymphoma.  In: Engert A, Horning S, editors. Hodgkin Lymphoma. A comprehensive update on diagnostics and clinics. Berliin: Springer Verlag; 2010. p. 163-182.

 

  • Maijenburg MW, Noort WA, Kleijer M, Kompier CJA, Weijer K, van Buul JD, van der Schoot CE, Voermans C. Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells. BRIT J HAEMATOL 2010;148(3):428-440.     [ PubMed ]

 

  • Maloney D, Morschhauser F, Linden O, Hagenbeek A, Gisselbrecht C. Diversity in antibody-based approaches to non-Hodgkin lymphoma. LEUKEMIA LYMPHOMA 2010;51(Suppl. 1):20-27.     [ PubMed ]

 

  • Milstein DMJ, te Boome LCJ, Cheung YW, Lindeboom JAH, van den Akker HP, Biemond BJ, Ince C. Use of sidestream dark-field (SDF) imaging for assessing the effects of high-dose melphalan and autologous stem cell transplantation on oral mucosal microcirculation in myeloma patients. ORAL SURG ORAL MED O 2010;109(1):91-97.     [ PubMed ]

 

  • Nur E, Arntzenius AB, Bokani N, Bruins-Slot W. Acute abdomen and liver enzyme abnormalities. NETH J MED 2010;68(6):268-+.  

 

  • Nur E, Brandjes DP, Schnog JJB, Otten HM, Fijnvandraat K, Schalkwijk CG, Biemond BJ. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients. BRIT J HAEMATOL 2010;151(1):62-69.     [ PubMed ]

 

  • Nur E, Mairuhu W, Biemond BJ, van Zanten AP, Schnog JJB, Brandjes DP, Otten HM. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis. AM J HEMATOL 2010;85(11):902-904.     [ PubMed ]

 

  • Oers MHJv. Hematologie (hoofdstuk 8).  In: Stehouwer CDA, Koopmans RP, Meer J van der, editors. Interne geneeskunde; 14e druk. Houten: Bohn Stafleu van Loghum; 2010. p. 245-281.

 

  • Oers MHJv. HOVON 101: een fase III, open label, gerandomiseerde multicentrische studie naar ofatumumab-onderhoudsbehandeling bij patienten met een recidief chronische lymfatische leukemie die in partiële of complete remissie zijn na re-inductiebehandeling. NED TIJDSCHR HEMATOL 2010;7(7):294-296.  

 

  • Persoon S, Kersten MJ, Chinapaw MJM, Buffart LM, Burghout H, Schep G, Brug J, Nollet F. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of a individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. BMC CANCER 2010;10(1):671.     [ PubMed ]

 

  • Scheffer PG, van der Schoot CE, Page-Christiaens GCML, Bossers B, van Erp F, de Haas M. Reliability of Fetal Sex Determination Using Maternal Plasma. OBSTET GYNECOL 2010;115(1):117-126.     [ PubMed ]

 

  • Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FAS, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJH, Costenbader KH, Criswell LA, Crusius JBA, Cui J, de Bakker PIW, de Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TWJ, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, Posthumus MD, Radstake TRDJ, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AHM, van der Horst-Bruinsma IE, van der Schoot CE, van Riel PLCM, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP, Wijmenga C, Karlson EW, Toes REM, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, Klareskog L, Plenge RM. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. NAT GENET 2010;42(6):508-U56.     [ PubMed ]

 

  • Tonino SH, van Gelder M, Eldering E, van Oers MH, Kater AP. R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia. LEUKEMIA 2010;24(3):652-654.     [ PubMed ]

 

  • Tromp JM, Tonino SH, Elias JA, Jaspers A, Luijks DM, Kater AP , van Lier RAW, van Oers MHJ, Eldering E. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering. ONCOGENE 2010;29(36):5071-5082.     [ PubMed ]

 

  • van Beers EJ, Biemond BJ, Schnog JJB. Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity". AM J HEMATOL 2010;85(3):217.     [ PubMed ]

 

  • Van der Plas EM, van den Tweel XW, Heijboer H, Geskus RB, Biemond BJ, Peters M, Fijnvandraat K. Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening.. PEDIATR CLIN AMSTERDAM 2010;21(1):5-6.  

 

  • van Meerten T, Hagenbeek A. CD20-Targeted Therapy: The Next Generation of Antibodies. SEMIN HEMATOL 2010;47(2):199-210.     [ PubMed ]

 

  • van Meerten T, Rozemuller H, Hol S, Moerer P, Zwart M, Hagenbeek A, Mackus WJM, Parren PWHI, van de Winkel JGJ, Ebeling SB, Martens AC. HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20low expressing tumor cells that resist rituximab-mediated lysis. HAEMATOL-HEMATOL J 2010;95(12):2063-2071.     [ PubMed ]

 

  • van Oers MHJ, Tönnissen E, van Glabbeke M, Giurgea L, Jansen JH, Klasa R, Marcus RE, Wolf M, Kimby E, Vranovsky A, Holte H, Hagenbeek A, van der Reijden BA. BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study. J CLIN ONCOL 2010;28(13):2246-2252.     [ PubMed ]

 

  • van Oers MHJ, Tönnissen E, van Glabbeke M, Giurgea L, Jansen JH, Klasa R, Marcus RE, Wolf M, Kimby E, Vranovsky A, Holte H, Hagenbeek A, van der Reijden BA. Reply to U. Duhrsen et al. J CLIN ONCOL 2010;28(30):e614.     [ PubMed ]

 

  • van Oers MHJ, van Glabbeke M, Giurgea L, Klasa R, Marcus RE, Wolf M, Kimby E, van T Veer M, Vranovsky A, Holte H, Hagenbeek A. Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study. J CLIN ONCOL 2010;28(17):2853-2858.     [ PubMed ]

 

  • van Rijssel RH, Wegman J, Oud ME, Pals ST, van Oers MHJ. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: Demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation. LEUKEMIA RES 2010;34(7):E142-E144.     [ PubMed ]

 

  • van Tuijn CFJ, Nur E, van Beers EJ, Zaaijer HL, Biemond BJ. Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection. AM J HEMATOL 2010;85(4):303-304.     [ PubMed ]

 

  • van Tuijn CFJ, van Beers EJ, Schnog JJB, Biemond BJ. Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease. AM J HEMATOL 2010;85(7):532-535.     [ PubMed ]

 

  • van Zaane B, Nur E, Squizzato A, Gerdes VEA, Büller HR, Dekkers OM, Brandjes DPM. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J THROMB HAEMOST 2010;8(11):2483-2493.     [ PubMed ]

 

  • Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JCM, Jukema JW, Schadt EE, van der Schoot E, Kastelein JJP, Khaw KT, Dullaart RPF, van Tol A, Trip MD, Dallinga-Thie GM. Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility. CIRCULATION 2010;122(5):470-U66.     [ PubMed ]

 

  • Vlaar APJ, Porcelijn L, van Rooijen-Schreurs IHM, Lardy NM, Kersten MJ, Juffermans NP. The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports. MED SCI MONITOR 2010;16(10):CS129-CS134.     [ PubMed ]

 

  • Vlaar AP, Wortel K, Binnekade JM, van Oers MHJ, Beckers E, Gajic O, Schultz MJ, Juffermans NP. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines. TRANSFUSION 2010;50(2):443-451.     [ PubMed ]

 

  • Zhang W, Kater AP, Widhopf GF II, Chuang HY, Enzler T, James DF, Poustovoitov M, Tseng PH, Janz S, Hoh C, Herschman H, Karin M, Kipps TJ. B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. P NATL ACAD SCI USA 2010;107(44):18956-18960.  
Auteur: B.M.J.M. Odijk, versie: 1, 19-03-2019